Virginia bills · 2026 Regular Session
Virginia SB 641
Office-based buprenorphine treatment; Board of Medicine to amend regulations.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Todd E. Pillion (Republican)
Cosponsors (12)
- Glen H. Sturtevant, Jr. (Republican)
- Richard H. Stuart (Republican)
- William M. Stanley, Jr. (Republican)
- Bryce E. Reeves (Republican)
- Mark J. Peake (Republican)
- Mark D. Obenshain (Republican)
- Tammy Brankley Mulchi (Republican)
- Ryan T. McDougle (Republican)
- T. Travis Hackworth (Republican)
- Timmy French (Republican)
- Christie New Craig (Republican)
- Luther Cifers, III (Republican)
Summary
Official abstract published by the Virginia legislature· SUMMARY AS PASSED
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to HB 712.
Text versions
Roll-call votes
State vote data last updated Oct 14, 2026, 12:15 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 24, 2026 House | H VOTE: | pass | Set your home in Virginia to see |
| Feb 19, 2026 House | Reported from Health and Human Services | pass | Set your home in Virginia to see |
| Feb 10, 2026 Senate | Passage R | pass | Set your home in Virginia to see |
| Feb 6, 2026 Senate | Constitutional reading dispensed R | pass | Set your home in Virginia to see |
| Feb 5, 2026 Senate | Reported from Education and Health | pass | Set your home in Virginia to see |
Actions
- Apr 6, 2026
Acts of Assembly Chapter text (CHAP0208) - Apr 6, 2026
Approved by Governor-Chapter 208 (effective 7/1/2026) - Mar 10, 2026
Governor's Action Deadline 11:59 p.m., April 13, 2026 - Mar 10, 2026 · Senate
Enrolled Bill communicated to Governor on March 10, 2026 - Mar 2, 2026 · Senate
Fiscal Impact statement From DPB (3/2/2026 2:20 pm) - Feb 26, 2026 · Senate
Signed by President - Feb 26, 2026 · House
Signed by Speaker - Feb 26, 2026 · Senate
Bill text as passed Senate and House (SB641ER) - Feb 26, 2026 · Senate
Enrolled - Feb 24, 2026 · House
Passed House (98-Y 0-N 0-A) - Feb 24, 2026 · House
Read third time - Feb 23, 2026 · House
Read second time - Feb 19, 2026 · House
Reported from Health and Human Services (21-Y 0-N) - Feb 13, 2026 · House
Referred to Committee on Health and Human Services - Feb 13, 2026 · House
Read first time - Feb 13, 2026 · House
Placed on Calendar - Feb 10, 2026 · Senate
Read third time and passed Senate (40-Y 0-N 0-A) - Feb 9, 2026 · Senate
Engrossed by Senate (Voice Vote) - Feb 9, 2026 · Senate
Read second time - Feb 6, 2026 · Senate
Passed by for the day - Feb 6, 2026 · Senate
Passed by for the day (Voice Vote) - Feb 6, 2026 · Senate
Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A) - Feb 6, 2026 · Senate
Rules suspended - Feb 5, 2026 · Senate
Reported from Education and Health (14-Y 0-N) - Jan 30, 2026 · Senate
Assigned Education sub: Health Professions - Jan 21, 2026 · Senate
Fiscal Impact Statement from Department of Planning and Budget (SB641) - Jan 14, 2026 · Senate
Referred to Committee on Education and Health - Jan 14, 2026 · Senate
Prefiled and ordered printed; Offered 01-14-2026 26104754D